BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34879042)

  • 1. Sphingomyelins and ceramides: possible biomarkers for dementia?
    Loft LMI; Moseholm KF; Pedersen KKW; Jensen MK; Koch M; Cronjé HT
    Curr Opin Lipidol; 2022 Feb; 33(1):57-67. PubMed ID: 34879042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased Serum Levels of Sphingomyelins and Ceramides in Sickle Cell Disease Patients.
    Aslan M; Kıraç E; Kaya S; Özcan F; Salim O; Küpesiz OA
    Lipids; 2018 Mar; 53(3):313-322. PubMed ID: 29663386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingolipid profiles are altered in prefrontal cortex of rats under acute hyperglycemia.
    Fiedorowicz A; Prokopiuk S; Zendzian-Piotrowska M; Chabowski A; Car H
    Neuroscience; 2014 Jan; 256():282-91. PubMed ID: 24161280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingolipidomic profile and HDL subfractions in obese dyslipidemic type 2 diabetic patients.
    Aslan İ; Aydın D; Koca Y; Yılmaz Ç; Çeker T; Öztüzün A; Aslan M
    Prostaglandins Other Lipid Mediat; 2023 Jun; 166():106719. PubMed ID: 36863606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingomyelin profiling in patients with diabetes could be potentially useful as differential diagnostics biomarker: A pilot study.
    Sokołowska E; Car H; Fiedorowicz A; Szelachowska M; Milewska A; Wawrusiewicz-Kurylonek N; Szumowski P; Krzyżanowska-Grycel E; Popławska-Kita A; Żendzian-Piotrowska M; Chabowski A; Krętowski A; Siewko K
    Adv Med Sci; 2022 Sep; 67(2):250-256. PubMed ID: 35785598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fatty acids of sphingomyelins and ceramides in mammalian tissues and cultured cells: Biophysical and physiological implications.
    Manni MM; Sot J; Arretxe E; Gil-Redondo R; Falcón-Pérez JM; Balgoma D; Alonso C; Goñi FM; Alonso A
    Chem Phys Lipids; 2018 Dec; 217():29-34. PubMed ID: 30359584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Intracellular Lipid Logistics in the Preferential Usage of Very Long Chain-Ceramides in Glucosylceramide.
    Yamaji T; Horie A; Tachida Y; Sakuma C; Suzuki Y; Kushi Y; Hanada K
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Milk polar lipids favorably alter circulating and intestinal ceramide and sphingomyelin species in postmenopausal women.
    Le Barz M; Vors C; Combe E; Joumard-Cubizolles L; Lecomte M; Joffre F; Trauchessec M; Pesenti S; Loizon E; Breyton AE; Meugnier E; Bertrand K; Drai J; Robert C; Durand A; Cuerq C; Gaborit P; Leconte N; Bernalier-Donadille A; Cotte E; Laville M; Lambert-Porcheron S; Ouchchane L; Vidal H; Malpuech-Brugère C; Cheillan D; Michalski MC
    JCI Insight; 2021 May; 6(10):. PubMed ID: 33857018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Sphingolipidomic Analysis in Acne Vulgaris Patients.
    Kaya S; Aslan İ; Kıraç E; Karaarslan T; Aslan M
    Ann Clin Lab Sci; 2019 Mar; 49(2):242-248. PubMed ID: 31028071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acid sphingomyelinase: No potential as a biomarker for multiple sclerosis.
    Leurs CE; Lopes Pinheiro MA; Wierts L; den Hoedt S; Mulder MT; Eijlers AJC; Schoonheim MM; Balk LJ; Uitdehaag BMJ; Killestein J; de Vries HE
    Mult Scler Relat Disord; 2019 Feb; 28():44-49. PubMed ID: 30553168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating ceramide ratios and risk of vascular brain aging and dementia.
    McGrath ER; Himali JJ; Xanthakis V; Duncan MS; Schaffer JE; Ory DS; Peterson LR; DeCarli C; Pase MP; Satizabal CL; Vasan RS; Beiser AS; Seshadri S
    Ann Clin Transl Neurol; 2020 Feb; 7(2):160-168. PubMed ID: 31950603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Very long-chain polyunsaturated fatty acids are the major acyl groups of sphingomyelins and ceramides in the head of mammalian spermatozoa.
    Furland NE; Oresti GM; Antollini SS; Venturino A; Maldonado EN; Aveldaño MI
    J Biol Chem; 2007 Jun; 282(25):18151-18161. PubMed ID: 17392275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Ceramides and Sphingomyelins in Relation to Heart Failure Risk.
    Lemaitre RN; Jensen PN; Hoofnagle A; McKnight B; Fretts AM; King IB; Siscovick DS; Psaty BM; Heckbert SR; Mozaffarian D; Sotoodehnia N
    Circ Heart Fail; 2019 Jul; 12(7):e005708. PubMed ID: 31296099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating Ceramides and Sphingomyelins and Risk of Mortality: The Cardiovascular Health Study.
    Fretts AM; Jensen PN; Hoofnagle AN; McKnight B; Sitlani CM; Siscovick DS; King IB; Psaty BM; Sotoodehnia N; Lemaitre RN
    Clin Chem; 2021 Nov; 67(12):1650-1659. PubMed ID: 34580702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a Specific Plasma Sphingolipid Profile in a Group of Normal-Weight and Obese Subjects: A Novel Approach for a "Biochemical" Diagnosis of Metabolic Syndrome?
    Rigamonti AE; Dei Cas M; Caroli D; De Col A; Cella SG; Paroni R; Sartorio A
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingomyelinase induces lipid microdomain formation in a fluid phosphatidylcholine/sphingomyelin membrane.
    Holopainen JM; Subramanian M; Kinnunen PK
    Biochemistry; 1998 Dec; 37(50):17562-70. PubMed ID: 9860872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limonoid compounds inhibit sphingomyelin biosynthesis by preventing CERT protein-dependent extraction of ceramides from the endoplasmic reticulum.
    Hullin-Matsuda F; Tomishige N; Sakai S; Ishitsuka R; Ishii K; Makino A; Greimel P; Abe M; Laviad EL; Lagarde M; Vidal H; Saito T; Osada H; Hanada K; Futerman AH; Kobayashi T
    J Biol Chem; 2012 Jul; 287(29):24397-411. PubMed ID: 22605339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ceramides and sphingomyelins with high proportions of very long-chain polyunsaturated fatty acids in mammalian germ cells.
    Furland NE; Zanetti SR; Oresti GM; Maldonado EN; Aveldaño MI
    J Biol Chem; 2007 Jun; 282(25):18141-18150. PubMed ID: 17392276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol interactions with ceramide and sphingomyelin.
    García-Arribas AB; Alonso A; Goñi FM
    Chem Phys Lipids; 2016 Sep; 199():26-34. PubMed ID: 27132117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating ceramides and sphingomyelins and the risk of incident cardiovascular disease among people with diabetes: the strong heart study.
    Jensen PN; Fretts AM; Hoofnagle AN; McKnight B; Howard BV; Umans JG; Sitlani CM; Siscovick DS; King IB; Sotoodehnia N; Lemaitre RN
    Cardiovasc Diabetol; 2022 Aug; 21(1):167. PubMed ID: 36042511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.